About Author

about the author

Chi-Hsin Richard King, Ph.D.

A prolific contributor to scientific literature, Dr. King’s scholarly output includes 28 peer-reviewed articles in esteemed scientific journals, showcasing his contributions to advancing knowledge in his field. Furthermore, his engagement with the scientific community is evidenced by his active participation in conferences, where he has presented 30 oral and poster presentations. Dr. King’s innovative spirit is also reflected in his impressive portfolio of 32 standalone patents. These patents cover a range of groundbreaking drug treatments addressing critical health issues, such as pneumonia, antibiotic-resistant bacteria, stem-cell mobilization therapy, major depressive disorder (MDD), and hepatitis C. His leadership and oversight of scientific teams and clinical trials coordination underscore his capacity to drive projects to fruition, from conceptualization to clinical application.
Dr. King’s executive roles further illustrate his leadership and vision in the biotechnology industry. Serving as the Chief Scientific Officer at American BriVision Corporation in Fremont, California, from 2017 to 2023, and before that, as the Senior Vice President at TaiGen Biotechnology Co. Ltd in Taipei, Taiwan, from 2005 to 2017, he has demonstrated an unwavering commitment to innovation and excellence. His earlier positions, including Director at Albany Molecular Research Inc. in Albany, New York, Program Director at the Industrial Technology Research Institute in Hsin-Chu, Taiwan, Section Head at Hoechst Marion Roussel (now part of Sanofi) in Cincinnati, Ohio, and Project Leader at The Dow Chemical Company in Midland, Michigan, further highlight his diverse experience and contributions to the field.
LEARN MORE
Dr. King earned his Ph.D. in organic chemistry from the University of Utah and his Bachelor of Science degree in chemistry from National Taiwan Normal University. This solid educational foundation has been the bedrock of his distinguished career, enabling him to pioneer advancements in biotechnology that continue to impact lives worldwide.